Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital

Carregando...
Imagem de Miniatura
Citações na Scopus
41
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC ARQUIVOS NEURO- PSIQUIATRIA
Citação
ARQUIVOS DE NEURO-PSIQUIATRIA, v.78, n.8, p.494-500, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with worse outcomes. Notwithstanding, the role of neurologists in COVID-19 is probably underrecognized. Objective: The aim of this study was to report the reasons for requesting neurological consultations by internists and intensivists in a COVID-19-dedicated hospital. Methods: This retrospective study was carried out at Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Brazil, a 900-bed COVID-19 dedicated center (including 300 intensive care unit beds). COVID-19 diagnosis was confirmed by SARS-CoV-2-RT-PCR in nasal swabs. All inpatient neurology consultations between March 23rd and May 23rd, 2020 were analyzed. Neurologists performed the neurological exam, assessed all available data to diagnose the neurological condition, and requested additional tests deemed necessary. Difficult diagnoses were established in consensus meetings. After diagnosis, neurologists were involved in the treatment. Results: Neurological consultations were requested for 89 out of 1,208 (7.4%) inpatient COVID admissions during that period. Main neurological diagnoses included: encephalopathy (44.4%), stroke (16.7%), previous neurological diseases (9.0%), seizures (9.0%), neuromuscular disorders (5.6%), other acute brain lesions (3.4%), and other mild nonspecific symptoms (11.2%). Conclusions: Most neurological consultations in a COVID-19-dedicated hospital were requested for severe conditions that could have an impact on the outcome. First-line doctors should be able to recognize neurological symptoms; neurologists are important members of the medical team in COVID-19 hospital care.
Palavras-chave
Coronavirus Infections, COVID-19, Neurology, Seizures, Stroke, Metabolic Encephalopathy, Neuromuscular Diseases
Referências
  1. Aggarwal G, 2020, INT J STROKE, V15, P385, DOI 10.1177/1747493020921664
  2. Benussi Alberto, 2020, Neurology, V95, pe910, DOI 10.1212/WNL.0000000000009848
  3. Bernard-Valnet R, 2020, EUR J NEUROL, V27, pE43, DOI 10.1111/ene.14298
  4. Bersano A, 2020, NEUROLOGY, V94, P905, DOI 10.1212/WNL.0000000000009508
  5. Bhidayasiri R, 2020, J MOV DISORD, V13, P105, DOI 10.14802/jmd.20042
  6. Dixon L, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000789
  7. Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
  8. Johns Hopkins University & Medicine, COVID 19 DASHB CTR S
  9. Kuroda N, 2020, EPILEPSY BEHAV, V108, DOI 10.1016/j.yebeh.2020.107122
  10. MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/BMJ.M1036
  11. Majersik JJ, 2020, NEUROLOGY, V94, P1055, DOI 10.1212/WNL.0000000000009564
  12. Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127
  13. Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
  14. Munhoz RP, 2020, ARQ NEURO-PSIQUIAT, V78, P290, DOI [10.1590/0004-282x20200051, 10.1590/0004-282X20200051]
  15. Novi G, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000797
  16. Paniz-Mondolfi A, 2020, J MED VIROL, V92, P699, DOI 10.1002/jmv.25915
  17. Parsons T, 2020, J NEUROL, V267, P2799, DOI 10.1007/s00415-020-09951-9
  18. Pilotto A, 2020, ANN NEUROL, V88, P423, DOI 10.1002/ana.25783
  19. Politi LS, 2020, JAMA NEUROL, V77, P1028, DOI 10.1001/jamaneurol.2020.2125
  20. Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
  21. Pranata R, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104949
  22. Radmanesh A, 2020, AM J NEURORADIOL, V41, P1179, DOI 10.3174/ajnr.A6610
  23. Romero-Sanchez Carlos Manuel, 2020, Neurology, V95, pe1060, DOI 10.1212/WNL.0000000000009937
  24. Rubin Michael A, 2020, Neurology, V95, P167, DOI 10.1212/WNL.0000000000009744
  25. Sellner J, 2020, EUR J NEUROL, V27, pE31, DOI 10.1111/ene.14257
  26. Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373
  27. Yin R, 2020, CLIN CHARACTERISTICS, DOI [10.1101/2020.04.29.20085415, DOI 10.1101/2020.04.29.20085415]